
The Board of Directors of Alterity Therapeutics (the “Company”) sets high standards for the Company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company’s business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Governance Documents
September 1, 2021 | Corporate Governance Statement 2021 | 134 KB | |
November 18, 2020 | ATH – Constitution (Amended) | 433 KB | |
April 29, 2020 | Board Charter | 1 MB | |
May 15, 2019 | Whistle Blower Policy | 320 KB | |
May 15, 2019 | Securities Trading Policy | 343 KB | |
May 15, 2019 | Diversity Policy | 197 KB | |
November 23, 2020 | 2018 ADS Plan (as amended) | 100 KB | |
November 23, 2020 | 2004 ASX Plan (as amended) | 52 KB |
Receive news from Alterity Therapeutics
